Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A0A3S7WP26
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 51 | 55 | PF00656 | 0.592 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.373 |
CLV_PCSK_KEX2_1 | 111 | 113 | PF00082 | 0.373 |
CLV_PCSK_KEX2_1 | 31 | 33 | PF00082 | 0.360 |
CLV_PCSK_PC1ET2_1 | 31 | 33 | PF00082 | 0.338 |
CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.342 |
CLV_PCSK_SKI1_1 | 112 | 116 | PF00082 | 0.338 |
CLV_PCSK_SKI1_1 | 57 | 61 | PF00082 | 0.266 |
CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.257 |
CLV_PCSK_SKI1_1 | 94 | 98 | PF00082 | 0.280 |
DOC_ANK_TNKS_1 | 49 | 56 | PF00023 | 0.591 |
DOC_CYCLIN_yCln2_LP_2 | 8 | 14 | PF00134 | 0.554 |
DOC_MAPK_MEF2A_6 | 10 | 18 | PF00069 | 0.606 |
DOC_MAPK_MEF2A_6 | 40 | 48 | PF00069 | 0.488 |
DOC_PP4_FxxP_1 | 12 | 15 | PF00568 | 0.608 |
DOC_WW_Pin1_4 | 119 | 124 | PF00397 | 0.575 |
DOC_WW_Pin1_4 | 161 | 166 | PF00397 | 0.523 |
LIG_14-3-3_CanoR_1 | 111 | 115 | PF00244 | 0.542 |
LIG_Actin_WH2_2 | 122 | 140 | PF00022 | 0.500 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.648 |
LIG_EH1_1 | 102 | 110 | PF00400 | 0.364 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.604 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.594 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.600 |
LIG_FHA_1 | 95 | 101 | PF00498 | 0.233 |
LIG_FHA_2 | 83 | 89 | PF00498 | 0.215 |
LIG_LIR_Gen_1 | 83 | 93 | PF02991 | 0.308 |
LIG_LIR_Nem_3 | 113 | 118 | PF02991 | 0.513 |
LIG_LIR_Nem_3 | 83 | 89 | PF02991 | 0.318 |
LIG_MYND_1 | 116 | 120 | PF01753 | 0.545 |
LIG_SH2_SRC | 52 | 55 | PF00017 | 0.584 |
LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.511 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.296 |
LIG_SH3_3 | 117 | 123 | PF00018 | 0.577 |
LIG_SUMO_SIM_par_1 | 13 | 20 | PF11976 | 0.476 |
MOD_Cter_Amidation | 109 | 112 | PF01082 | 0.462 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.330 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.502 |
MOD_NEK2_2 | 110 | 115 | PF00069 | 0.542 |
MOD_PKA_2 | 110 | 116 | PF00069 | 0.533 |
MOD_Plk_1 | 42 | 48 | PF00069 | 0.484 |
MOD_Plk_1 | 82 | 88 | PF00069 | 0.393 |
MOD_ProDKin_1 | 119 | 125 | PF00069 | 0.573 |
MOD_ProDKin_1 | 161 | 167 | PF00069 | 0.530 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTD3 | Leptomonas seymouri | 74% | 100% |
A0A0S4JQI6 | Bodo saltans | 29% | 100% |
A0A1X0NJU2 | Trypanosomatidae | 51% | 100% |
A0A1X0NR99 | Trypanosomatidae | 34% | 100% |
A0A3S7X736 | Leishmania donovani | 32% | 100% |
A0A422N2T1 | Trypanosoma rangeli | 54% | 100% |
A0A422NKR0 | Trypanosoma rangeli | 34% | 100% |
A4H495 | Leishmania braziliensis | 89% | 100% |
A4HLZ1 | Leishmania braziliensis | 30% | 100% |
A4I9C1 | Leishmania infantum | 32% | 100% |
C9ZJA0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
C9ZUD9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 100% |
E9AKF5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
E9B4C0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
Q4Q3Q5 | Leishmania major | 32% | 100% |
V5BJW3 | Trypanosoma cruzi | 50% | 100% |
V5DB75 | Trypanosoma cruzi | 33% | 100% |